Clinical Trials Directory

Trials / Completed

CompletedNCT02034383

The Effect of Processing on the Measured Energy Value of Almonds in the Human Diet

Macronutrient Absorption From Almonds: The Effect of Processing on the Measured Energy Value of Almonds in the Human Diet

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
18 (estimated)
Sponsor
David Baer · Federal
Sex
All
Age
25 Years – 75 Years
Healthy volunteers
Accepted

Summary

The objective of this study is to measure the effect of processing (roasting, slicing, or grinding) on the energy value of almonds in the human diet and study molecular mechanisms that may help explain the beneficial health effects of almonds.

Detailed description

The metabolizable energy values, or Atwater general factors, for protein, fat, and carbohydrate are commonly used to calculate the metabolizable energy of a diet. Atwater factors are based on average values of mixed diets and are not exact; thus, using these values could introduce an error in the calculated metabolizable energy of a particular food due to differences in chemical structure and availability. Studies have demonstrated that Atwater general factors overestimate the energy derived from protein and fat, as well as the measured metabolizable energy of mixed diets, particularly those that are high in dietary fiber. Studies are lacking, however, that examine how different processing methods affect the metabolizable energy of a food due to differences in chemical structure and availability.

Conditions

Interventions

TypeNameDescription
OTHERControlControlled diet for 3 weeks with 0 servings/day of almonds.
OTHERWhole AlmondsControlled diet for 3 weeks with 1.5 servings/day of whole, natural almonds.
OTHERRoasted Whole AlmondsControlled diet for 3 weeks with 1.5 servings/day of roasted whole almonds.
OTHERDiced AlmondsControlled diet for 3 weeks with 1.5 servings/day of diced almonds.
OTHERAlmond ButterControlled diet for 3 weeks with 1.5 servings/day of almond butter.

Timeline

Start date
2014-03-01
Primary completion
2014-07-01
Completion
2014-07-01
First posted
2014-01-13
Last updated
2015-02-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02034383. Inclusion in this directory is not an endorsement.